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Male Circumcision and Infection
Ruth Mielke
Abstract
Worldwide, male circumcision is done for religious or cultural reasons, and to a 
lesser degree for medical indications. Newborn male circumcision is associated with 
fewer genitourinary infections in younger males. In the current decade, a substan-
tial body of research suggests that male circumcision is effective as a prophylactic 
measure against HIV and other sexually transmitted infections. The compelling 
HIV reductions in 3 African randomized control trials in circumcised men have 
prompted use of male circumcision as a key part of HIV prevention in developing 
nations. More recently, the use of male circumcision as a public health measure in 
developed nations is a topic of international discussion.
Keywords: male circumcision, sexually transmitted infections,  
sexually transmitted diseases, HIV, urinary tract infection, HPV
1. Introduction
Historically, male circumcision has been done for religious/cultural reasons 
and to a lesser degree, for medical indications. Contemporary discussion of male 
circumcision relates to its utility as a public health measure – specifically in the 
prevention of genitourinary and sexually transmitted infections. Male circumcision 
was suggested to prevent sexually transmitted infection as early as the 1850s [1] and 
broadly as a “sanitary measure” in 1914 [2]. However, when three large randomized 
controlled trials in sub-Sahara Africa reported that male circumcision reduced 
the risk of acquiring HIV infection in males by as much as 60%, [3–5] attention 
to its health benefits became a world-wide discussion. In 2007, the World Health 
Organization (WHO), and the Joint United Nations Programme on HIV/AIDS 
(UNAIDS), announced that male circumcision was integral to comprehensive HIV 
prevention [6, 7].
Most professional organizations in developed nations do not recommended 
routine use of newborn male circumcision but recognize its use in disease preven-
tion. The American Urological Association, Canadian Paediatric Society, Canadian 
Urological Association and Royal Australasian College of Physicians recognize a 
benefit for some boys in high-risk populations [8–11]. However, the Centers for 
Disease Control supports infant and later age MC and the American Academy of 
Pediatrics endorses newborn MC; e.g. “current evidence indicates that the health 
benefits of newborn male circumcision outweigh the risks, and the benefits of 
newborn male circumcision justify access to this procedure for those families who 
choose it” [12, 13].
This chapter will discuss the impact of male circumcision in the context of the 
health promotion and health prevention specific to genitourinary and sexually 
transmitted infections.
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2. Physiology of the foreskin
Male circumcision involves cutting and removing all or part of the foreskin, or 
prepuce, from the glans penis. To understand the rationale for the use of male circum-
cision (MC) in prevention of infections, it is important to understand the function 
and physiology of the foreskin. At birth, the glans penis and inner foreskin share a 
common, fused mucosal epithelium called the balano-preputial lamina (BPL). Much 
like the membrane that fuses the fingernail to the finger, it acts as “living glue”. ‘The 
extent of this fusion is such that the foreskin can only be retracted in 4% of newborn 
boys resulting in physiologic phimosis; natural inability to separate the foreskin. As the 
penis grows in the first 3–4 years of the boy’s life, the foreskin gradually separates from 
the glans when smegma, epithelial debris produced by sebaceous glands, accumulates 
under the foreskin [14]. By age 10 most boys have a retractable foreskin, and by age 17, 
natural separation of the foreskin from the glans penis is complete [15] (Figure 1).
2.1 Uncircumcised
There are divergent viewpoints on the purpose and function of the foreskin. MC 
opponents view the keratinized squamous epithelium that covers the penile shaft 
and the foreskin in the uncircumcised penis as having protective functions. Beyond 
being epithelial debris, smegma is a natural emollient that protects and lubricates 
the glans. One author’s suggestion that the inner foreskin contains apocrine glands 
that secrete substances e.g. lysozymes and cytokines with antibacterial properties 
[16] has not been verified in biochemical research. It is contended that neonatal 
male circumcision not only removes tissue containing fine-touch receptors but 
interferes with the natural separation process. This may lead to subsequent sensory 
imbalance and risk of injury and tears that make the circumcised penis less hygienic 
and more prone to infection [17].
2.2 Circumcised
The alternate view is that the biochemical and structural properties of the intact 
foreskin result in increased acquisition of HIV and other STIs. During intercourse, 
the foreskin slides backward and exposes the inner mucosal surface with its high 
density of target cells for HIV, Langerhans cells, CD4+ cells, and macrophages - 
providing an entry point for pathogens. Lymphoid areas of mucosal surfaces are 
primary sites for HIV infection. Foreskin tissue has been identified as both hav-
ing abundant HIV target cells and susceptibility to trauma because of its thinly 
keratinized surface [18]. Structurally, the folding of the foreskin on the non-erect 
Figure 1. 
Physiologic changes in the male foreskin and balano-preputial lamina (BPL) over time.
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uncircumcised penis creates a sub-preputial space which is eliminated on the erect 
penis. By removing the foreskin surgically, this space is eliminated thereby remov-
ing the reservoir for HIV, human papilloma virus (HPV), and other pathogens 
[19–21]. In theory, removal of the foreskin HIV reduces target cells, eliminates the 
sticky medium for viruses, exposes the more keratinized penile shaft and eliminates 
the sub-preputial space which collectively diminishes pathogen exposure.
3. Urinary tract infection
Urinary tract infection (UTI) is one of the more common bacterial infections in 
children with 1–3% of children experiencing one UTI in early childhood [22, 23]. 
The strongest risk factors are renal tract abnormalities, which are relatively rare 
[24]. Common risk factors are female gender, young age, and uncircumcised state 
in boys [22, 25, 26]. A population study in Australia (N = 2856), conducted over 
12.8 years in which most males (80.7%) were uncircumcised, reported the preva-
lence of UTI as twice (5.3%) in girls than in boys (2.1%) [25]. An epidemiologic 
study of 596 cases of childhood UTI in Sweden, where circumcision is uncommon, 
reported the prevalence of UTI by 11 years of age to be 3.0% for girls and 1.1% 
for boys. [23] Other sex differences observed by were that the prevalence of UTI 
was highest during the first month of life and then decreased more rapidly in boys 
than in girls [23, 27]. As the uncircumcised foreskin may support the growth of 
pathogenic bacteria at the meatus [28], this decline in UTI prevalence in boys likely 
occurred because of the physiologic retraction of the prepuce over time [16].
3.1 Current research
The associations of MC and UTI in older studies were limited due to having samples 
with disproportionately larger groups of circumcised boys and generally, because of 
being single studies of observational, non-experimental design. More robust evidence 
of the disease prevention potential of MC with respect to UTI has come about from 
more recent multi-study reviews [26, 29]. One of these, a meta-analysis of 22 studies 
(21 observational and one randomized controlled trial of 70 participants) examined 
lack of circumcision as a risk factor for UTI and reported a lifetime relative risk of UTI 
as 3.7 times higher than that in uncircumcised males. Stratified for age, the risk of UTI 
was 9.91 greater for those aged 0–1 year; 6.56 greater for those aged 1–16 years; and 3.41 
for those older than 16 years, in uncircumcised males [26]. These results are consistent 
with the known decline of UTIs in males as they mature, but also suggest that the effect 
of MC in UTI prevention is most evident in infants and younger boys.
3.2 High-risk populations
Recurrent UTIs are the principal cause of permanent kidney tissue scarring 
in children, so interventions that reduce frequency of UTIs are needed to pre-
vent short and long-term morbidity. Vesicoureteral reflux (VUR), an abnormal 
retrograde or “back” flow of urine from the bladder to the upper urinary tract, 
is the most common abnormality of the urinary tract in children and is found in 
30–40% of children with UTI [30]. In children with VUR, risk of UTI recurrence 
increases to 10 and 30% [31]. One review of 12 studies (one RCT, 4 cohort stud-
ies, and 7 case-control studies) used a meta-analysis to assess the effect of MC 
on UTI, and then estimated the degree of benefit in normal boys compared to 
those with (a) recurrent UTI and (b) VUR, who have increased risk of UTI. Male 
circumcision was associated with a significantly reduced risk (87%) of UTI [31]. 
However, given the low risk of UTI in normal boys (1%) they estimated that 
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the number of MC needed to prevent one UTI was 111. However, in higher risk 
boys, the number of MC needed to treat those with recurrent UTIs was reduced 
to 11 and for those with VUR to 4 [31]. This suggests that use of MC particularly 
in higher risk groups of boys is an intervention to reduce UTI, subsequent renal 
scarring and loss of renal reserve.
Prenatal hydronephrosis (fetal urinary tract dilatation), is one of the most 
common congenital urological anomalies, and is reported in 1–2% of all pregnan-
cies [32]. Prenatal identification of high-grade hydronephrosis has been associated 
with VUR and 3-fold increase in UTIs, so such findings may warrant consideration 
of early infant male circumcision [33]. Genetics has increasing importance in 
identifying those at risk for recurrent UTI. Genes have been identified that cause 
inefficient bacterial clearance and greater susceptibility to UTIs [34]. Syndromes 
in which there are genital tract anomalies, most prominently, vesicoureteral reflux, 
may increase the risk for recurrent UTI [24, 32, 33]. Early infant male circumci-
sion (EIMC) may be warranted in boys who are at risk for recurrent UTIs based on 
prenatal findings.
4. Sexually transmitted infections
Worldwide, more than 1 million sexually transmitted infections (STIs) are acquired 
daily [35, 36]. Organisms causing STIs are bacterial, protozoal, and viral. Those with 
bacterial (chlamydia, gonorrhea, syphilis) or protozoal (trichomonas) causes are 
treatable while those caused by viruses (herpes simplex, human papilloma, HIV) are 
not [36, 37]. Each year, 376 million new infections are caused by chlamydia, gonor-
rhea, syphilis and trichomonas and more than 500 million persons experience genital 
infections from herpes simplex virus (HSV) [36, 38] (Figure 2). Most STIs have no 
symptoms or only mild symptoms that may not be recognized as an STI. Further, STIs 
such as HSV type 2 and syphilis increase the risk of HIV acquisition. Longer term, STIs 
can have serious reproductive health consequences beyond the immediate impact of 
the infection such as infertility, mother-to-child transmission and genitourinary can-
cers. Moreover, people with sexually transmitted infections often experience stigma, 
stereotyping, vulnerability, shame and gender-based violence [35].
Figure 2. 
Estimated prevalence of chlamydia, gonorrhea, trichomoniasis and active syphilis in women aged 15–49 years 
by WHO region, 2009–2016 Source: WHO Report on global sexually transmitted infection surveillance, 2018.
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4.1 HIV
The health burden of HIV infections is greatest in developing countries where HIV 
is more prevalent, and treatment is least available. Figure 3 shows geographic extremes 
ranging from 0.1% to nearly 5% in Africa. Of the 39.3 million persons living with HIV 
worldwide, nearly 70% live in Sub-Saharan Africa [39]. Of those, adolescent girls and 
women account for a disproportionate percentage (59%) of new HIV infections among 
adults aged 15 and older. This contrasts with other parts of the world, where men 
account for 63% of the new adult HIV infections. Globally, there were almost 90,000 
more new HIV infections among men than women in 2017 [40]. Therefore, reaching 
more men with HIV treatment but more proactively, with preventive measures such 
as circumcision, is critical to breaking cycles of HIV transmission and reducing HIV 
incidence among young women. If fewer men acquire HIV because of male circumci-
sion, this will benefit women by reducing exposure to HIV-infected men.
4.1.1 Heterosexual transmission
The potential of male circumcision to protect from heterosexual HIV infec-
tion was first suggested in 1986 [41]. Subsequently, a rich body of research done 
in developing countries has emerged focusing on the relationship between male 
circumcision and heterosexual HIV acquisition in men. In a review of (1) biological 
evidence, (2) observational study data supported by high-quality meta-analyses, 
and the (3) results of three well-recognized randomized clinical trials [3–5] 
(Table 1) and high-quality meta-analyses [42, 43] from 1999 to 2011, all of the high-
est quality studies; Grades 1 and 2 (meta-analyses and randomized control trials) 
favored MC in terms of reducing HIV risk as did the vast majority of the Grades 3 
and 4 (case-control/observational studies and expert opinion) studies [44].
A more recent meta-analysis evaluated the effect of male circumcision on HIV 
acquisition for HIV (−/+) males and HIV (−) females during heterosexual behavior. 
The analysis of fifteen studies (4 RCTs and 11 prospective cohort) reported strong evi-
dence that male circumcision was associated with reduced HIV acquisition for HIV (−) 
Figure 3. 
Prevalence of HIV among adults aged 15 to 49, 2016 by WHO region.
Circumcision and the Community
6
males during sexual intercourse with females (70% protective effect) but no difference 
was detected in HIV acquisition for HIV (−) females between the circumcised and 
uncircumcised groups [45]. One of the RCTs that evaluated the effect of MC in HIV 
(+) and (−) men on their female partners was stopped early in that MC did not prevent 
female HIV infection in either group [46]. Although the women in the studies did not 
experience individual protective benefit of HIV from partners with MC, the reduction 
of HIV in men with MC is important from a population reduction perspective.
A study of heterosexual men in a Baltimore, Maryland (United States) reported 
that 1096 (2.7%) of clinic visits yielded positive HIV test results. Among 394 visits 
by patients with known HIV exposure, circumcision was significantly associated 
with lower HIV prevalence (10.2 vs. 22.0%) [87]. This suggests that MC may have a 
role in HIV prevention in resource rich countries as well.
The optimal time for MC is when the man is HIV (−) but there may be benefit in 
HIV (+) men as well. WHO/UNAIDS have recommended that MC not be denied to 
Male circumcision and HIV and STI acquisition in men and transmission to female partners
Ratio (95% confidence interval) by study locationa
Uganda South Africa Kenya
N = 4996 N = 3274 N = 2784
Male protection benefit
 HIV 0.43 (0.24–0.75)b 0.40 (0.24–0.68)b 0.47 (0.28–0.78)b
 High-risk HPV 0.65 (0.46–0.90)c 0.68 (0.52–0.89)c
 HSV-2 0.72 (0.56–0.92)d 0.66 (0.32–1.12)b
 Syphilis 1.10 (0.75–1.65)d
 Neisseria gonorrhoeae 0.87 (0.60–1.26)c 0.95 (0.68–1.34)b
 Chlamydia trachomatis 0.56 (0.32–1.00)e 0.87 (0.65–1.16)b
 Trichomonas vaginalis 0.53 (0.28–1.02)e 0.77 (0.44–1.36)b
 GUD 0.53 (0.43–0.64)c
Female protection benefit
 HIV 1.49 (0.62–3.57)d
 Bacterial vaginosis (any) 0.60 (0.38–0.94)c
 Bacterial vaginosis (severe) 0.39 (0.24–0.64)c
 Trichomonas vaginalis 0.52 (0.05–0.98)c
 GUD 0.78 (0.63–0.97)c
 High-risk HPV 0.72 (0.60–0.85)c
Adapted with permission of John Wiley and Sons.
Abbreviations: GUD, genital ulcer disease; HIV, human immunodeficiency virus; HPV, human papillomavirus; 
HSV-2, herpes simplex virus type 2; STI, sexually transmitted infection.
aData shown are from 3 randomized controlled trials by Gray et al. [5], Auvert et al. [3], and Bailey et al. [4], that 
presented the effect of male circumcision on HIV/STI acquisition in men, 2 RCTs and a secondary analysis related to 
the Ugandan study on effect of MC in HIV (−/+) men on female partners by Wawer et al. [46], MC effect on HPV 
acquisition in female partners by Wawer et al. [60], and a MC effect on female partner STI acquisition by Gray 
et al. [85]. All ratios are adjusted (except for South African HSV-2 and Kenyan bacterial STIs) and represent an 
intention-to-treat analysis.
bThe ratio expressed is an incidence rate ratio.
cThe ratio expressed is a prevalence risk ratio.
dThe ratio expressed is a hazard ratio.
eThe ratio expressed is an odds ratio.
Table 1. 
Male circumcision and HIV and STI acquisition in men and transmission to female partners.
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HIV-infected men who request the procedure (unless there are medical contraindi-
cations) to reduce stigma but also as MC can reduce acquisition of HPV in men and 
syphilis and herpes in their female partners [47–49]. Further, including all males in 
voluntary medical male circumcision programs, irrespective of HIV status, results 
in greater population uptake as higher risk HIV (−) males who may otherwise avoid 
programs due to fear of being tested for HIV will be more likely to participate [50]. 
In an RCT of HIV-positive men in Uganda, MC did not reduce HIV transmission to 
women over a period of 2 years [48]. However, the higher rate of HIV transmission 
in couples who initiated intercourse soon after MC compared to those who waited 
until healing occurred, underscores the importance of delaying intercourse until 
the MC wound is healed.
Therefore, MC protects men from HIV infection in areas where prevalence of HIV 
(e.g. sub-Saharan Africa) is high, is largely due to heterosexual transmission, and where 
access to antivirals is low. Male circumcision does not appear to decrease HIV acquisi-
tion in their female partners on an individual level but decreasing new HIV infections 
overall will ultimately reduce the HIV burden in the population overall.
4.1.2 Homosexual transmission
The case for MC as a preventive measure is less compelling in areas where HIV 
acquisition is largely due to men who have sex with men. In developed countries, 
where HIV prevalence overall is low, most HIV are cases are related to homosexual 
transmission e.g. in the United States, 66%, [51, 52]. Further, developed countries 
have access to antivirals for prevention as well as for treatment of HIV infection 
which keep prevalence of new infections and AIDs mortality low. One review of 20 
observational studies (N = 71,693), reported that the pooled effect estimate for HIV 
acquisition in homosexual men was not statistically significant. However, when 
subgroups were analyzed, the results of 7 studies of men reporting an insertive role 
were statistically significant for a 27% reduction in HIV acquisition in contrast to 
the 3 studies of men reporting a receptive role [53]. However, a more recent meta-
analysis by Sharma et al. that examined the impact of sexual roles among homo-
sexual men reported that MC did not definitively have a protective effect among 
predominantly insertive homosexual men or receptive men but acknowledged that 
there were a small number of studies reporting the effect of sexual role on HIV 
acquisition [54].
More broadly, the Sharma et al. meta-analysis of 49 studies was conducted 
to assess MC as a method to prevent HIV acquisition in homosexual and/or 
heterosexual men. The overall pooled risk ratio (RR) for both homosexual and 
heterosexual men was 0.58 (95% CI 0.48–0.70), suggesting that MC was associ-
ated with a reduction in HIV risk. Heterosexual men had a greater risk reduction 
(72%) compared with 20% for homosexual men. However, there was significant 
heterogeneity among the studies and less than 6% of total subject count was from 
randomized controlled trials [54]. Although the study suggests that MC was effec-
tive in reducing HIV risk for both heterosexual and homosexual men, the effect was 
dramatically lower in homosexual men.
Male circumcision represents one of very few proven HIV prevention strate-
gies particularly in high prevalence areas, such as sub-Saharan Africa where 
transmission is largely related to heterosexual contact. It is less clear whether 
voluntary male medical circumcision programs, such as those employed in 
Africa would be as beneficial in developed nations. In the United States, HIV 
prevalence is comparatively low and most new HIV infections are attributed to 
men having sex with men. Theoretically, certain groups in the United States, 
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e.g. African-American and Hispanic men with higher risk of HIV infections 
could benefit but this impact would be much less profound [12]. In addition, the 
reality that individuals may identify as either homosexual or heterosexual but are 
bisexually active further confounds the potential effect of MC on homosexual 
 transmission of HIV.
4.2 Human papilloma virus
Human papillomavirus (HPV) has been established as the leading cause of inva-
sive cervical cancer in women and is associated with anogenital warts and cancers 
in men and women [55]. Of the 100+ strains of HPV; about 40 affect the anogenital 
areas. HPV strains are classified as either low-risk (causes benign lesions) or high-
risk (causes malignancies). Oncogenic high-risk strains (e.g. HPV types 16 and 18) 
cause most of the HPV-related cancers and pre-cancers, while the low-risk strains 
cause genital warts or mild Pap test abnormalities. Most sexually active persons will 
contract HPV infection at some time in their lives but in most cases, the infection 
will be asymptomatic and clear spontaneously. Risk factors associated with HPV 
infection include, increased exposure to the virus via multiple partners, decreased 
condom usage, history of other STIs, tobacco usage, and for women, having sex 
with an uncircumcised partner [56].
4.2.1 HPV in women
More than 290 million women have human papillomavirus (HPV) infection [57]. 
Worldwide, cervical cancer is the fourth most frequent cancer in women and fourth 
leading cause of death in women. In developing countries, cervical cancer ranks 
second (breast cancer is first) in incidence and mortality. Approximately 90% 
of deaths from cervical cancer occur in low- and middle-income countries where 
women do not have access to pap testing and HPV vaccine [58, 59]. Absent of such 
health resources, MC in their partners provides a means of HPV prevention and 
exposure reduction for women.
A challenge to ascertaining associations between a woman’s HPV risk and her 
partner’s circumcision status is the reality that she may have numerous partners 
in her lifetime. A study of HPV and cervical cancer in women with only one male 
partner demonstrated HPV infection of 5.5% in circumcised versus 19.6% of 
uncircumcised men [19]. Therefore, the procedure of MC itself removes a reservoir 
for viruses, such as HPV, thus reducing exposure over the long-term.
As the precursor of cervical cancer, reducing high-risk HPV transmission is 
a critical part of disease prevention. Decreased prevalence of high-risk HPV was 
found in an RCT of Ugandan women whose long-term partners were circumcised 
immediately compared with women with partners who were circumcised 24 months 
after enrollment [60] (Table 1). The significant reduction (28%) in high-risk HPV 
that was observed in women whose partners were circumcised earlier suggests that 
MC has a role in reducing HPV exposure to women in areas where HPV vaccine is 
not readily available.
A systematic review by Grund et al. analyzed data from 60 studies on the 
influence MC on women’s health outcomes [47]. In the cervical cancer and cervical 
dysplasia groups, there were no RCTs, but the quality of the studies was graded 
using the Newcastle-Ottawa scale for non-randomized studies. All but one of the 
studies reported a highly protective effect of MC related to cervical cancer (in the 
exception study only 11% of the men were circumcised) [61]. In the same review, 
four of the five cases reviewed also showed that MC was highly protective of cervi-
cal dysplasia and moderately protective of HPV infection. In developed countries, 
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access to HPV vaccination along with early identification and treatment of cervical 
dysplasia is a well-established part of preventive health care for women. In resource 
poor countries without such preventive care programs, the protective effect of MC 
on cervical dysplasia and cancer offers a critical means of preventing morbidity and 
mortality in women.
4.2.2 HPV in men
HPV is the most common STI in the world. More attention has been on HPV 
infection in women because of its association with cervical cancer. In men, mani-
festations of HPV infection range from genital warts and mild dysplasia (low-risk 
strains) to rarely, anogenital cancers (high-risk strains). Two of the African trials 
[3, 5] (Table 1) reported that MC was associated with an estimated 33% reduced 
occurrence of high-risk HPV virus in men. Two reviews and meta-analyses ana-
lyzed the effect of male circumcision on genital HPV infection in men. Albero et al. 
(21 studies; N = 14,382) reported that MC was associated with a 43% reduction in 
both low- and high-risk strains of HPV and in two studies (RCTs), 33% reduction in 
high-risk HPV. However, no associations were found in the acquisition of new HPV 
infections, genital HPV clearance, or genital warts [62]. Larke et al. (27 studies; 
N = 10,779) also reported that MC was associated with modest (25%) HPV reduc-
tion but no evidence of an association with genital warts [63]. However, Larke et al. 
reported 33% increased HPV clearance after MC which is important when consid-
ering that diminishing viral load in men reduces exposure to their female partners.
Penile cancer is rare—globally with 0.84 cases per 100,000 person-years [64]. 
High-risk HPV infection has a considerable role in penile cancer, but with less 
consistency than in cervical cancer. In contrast to cervical cancer, in which HPV is 
responsible for nearly all cases, HPV infection is associated with penile cancer from 
55 to 82% of the time [65]. In a study of HIV-positive men in Uganda, MC reduced 
the prevalence and incidence of multiple HR-HPV infections. Multiple HR-HPV 
infections were found in 22.4% of subjects in the intervention (MC) group and in 
42.5% of those in the control (no MC) group demonstrating 47% efficacy [48]. 
Therefore, male circumcision may provide a direct benefit for HIV-positive men by 
preventing penile HR-HPV infection and thus potentially averting penile cancer. In 
addition, it is possible that circumcision of HIV-infected men may protect female 
partners from infection and potentially from cervical neoplasia.
5. Other sexually transmitted infections
Male circumcision has a role in the acquisition of other sexually transmitted infec-
tions. Although MC has not been directly associated with decreases in HIV transmis-
sion to female partners [5] (Table 1) it is still important to understand whether MC 
affects ulcerative sexually transmitted infections such as HSV type 2 [66–68] and 
syphilis [67, 69] both of which are associated with an increased risk of HIV.
5.1 Herpes simplex virus
Infection with the herpes simplex virus (HSV) is due to herpes simplex 
virus type 1 (HSV-1) or herpes simplex virus type 2 (HSV-2). HSV-1 is mainly 
transmitted by oral contact to cause infection in or around the mouth (oral 
herpes). HSV-2 is almost exclusively sexually transmitted, causing infection in 
the genital or anal area (genital herpes) [70]. HSV infection is highly stigmatized 
and negatively impacts relationships. However, more critical is its potential for 
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perinatal transmission, resulting newborn morbidity and mortality [71–73] and 
its well-documented relationship with HIV.
Perinatal transmission mostly occurs during delivery from mothers with herpes 
simplex virus HSV-1 or HSV-2 genital infection. If contracted, 60% of newborns 
will die without treatment [73]. In a first estimate of global neonatal herpes infec-
tion, Looker et al. reported 14,000 neonatal herpes cases annually and that most 
neonatal herpes cases occurred in Africa, due to high maternal HSV-2 infection 
and high birth rates. HSV-1 contributed more cases than HSV-2 in the Americas, 
Europe, and Western Pacific [72]. Therefore, understanding the relationship 
between MC and HSV transmission is important as circumcision may afford 
important benefit in terms of reductions in HSV infections, particularly in female 
partners in their childbearing years.
HSV-2 is a leading cause of genital ulcer disease worldwide, but prevalence by 
global region differs [71]. Looker et al. reported that Africa had the highest preva-
lence (32%), followed by the Americas (14%), with Africa contributing most to the 
global totals due to combined large population and high prevalence. Despite their 
lower prevalence, South-East Asia (8%) and Western Pacific (8%) also contributed 
large numbers infected to the global totals due to their large population numbers [38].
Women are more likely to acquire HSV-2 than men and certain ethnicities are at 
greater risk. For instance in the United States, the prevalence of HSV-2 in adults is 
12.1%; but affects women (15.9%) more so than men (8.2%) and is highest among non-
Hispanic black persons (34.6%) [74]. In Africa, HSV-2 prevalence in men ranged from 
5.9 to 39.8% while in women, from 29.2% (rural women) to 79.9% (sex workers) [75].
Two of the African RCTs reported that MC was associated with HSV-2 reductions 
of 28 and 34% in men [3, 5] (Table 1). Subsequently, a large meta-analysis (N = 49) 
supported this original finding with respect to HSV reductions in men in that MC 
diminished risk of HSV-2 by 15% and genital ulcers (often due to HSV-2) by 20% 
[54]. There are fewer reports of the relationship between MC and HSV infections 
in the female partners. However, in the Grund et al. systematic review of MC and 
women’s health outcomes, the direction of the evidence in the six studies (including 
one RCT) was highly protective of HSV-2 [47]. Five of the studies were in developing 
countries and one was in the U.S. suggesting greater global generalizability.
The HIV epidemic in sub-Saharan Africa is known to be fueled by HSV-2 
consequently directing attention on the prevalence and transmission of HSV-2 in 
in recent years [68, 75]. Abu-Rabbad et al. estimated that in areas of high HSV-2 
prevalence, such as Kisumu, Kenya, more than a quarter of incident HIV infec-
tions may have been attributed directly to HSV-2 [68]. Therefore, the role of MC in 
reducing HSV-2 transmission has the potential for short-term benefit along with 
long-term influence in perinatal health promotion and disease prevention.
5.2 Syphilis
Syphilis can cause neurological, cardiovascular and dermatological disease in 
adults, and stillbirth, neonatal death, premature delivery or severe disability in 
infants [36]. Women of childbearing age are a particularly vulnerable population. 
During pregnancy, the immunosuppression of pregnancy increases risk of syphilis 
acquisition and if untreated or undertreated, there is great risk for adverse infant 
consequences. In 2016, 988,000 pregnant women worldwide were infected with 
syphilis, resulting in over 350,000 such adverse outcomes including 200,000 
stillbirths and newborn deaths [76].
The interaction between syphilis and HIV is complex and continues to be 
studied [69]. The World Health Organization has identified dual elimination of HIV 
and syphilis as a global health priority [77]. In the early stages of syphilis, painless 
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genital sores (chancres or ulcers) facilitate transmission of HIV infection sexu-
ally. Conversely, the immunocompromised state of HIV infection makes syphilis 
acquisition more likely. In developed countries, homosexual (men having sex with 
men) are the largest affected group [78, 79]. However, recent increases in congenital 
syphilis in developed [78] and developing countries warrant attention to the learn-
ing the potential value of MC in prevention of syphilis acquisition in women as well.
Several reviews have studied the influence of MC and syphilis. Weiss et al. 
studied risk of three ulcerative STIs (syphilis, chancroid, and genital herpes) and 
reported that of the syphilis studies (N = 14), there was substantial reduction of 
syphilis (33%) in men; however, this was limited by significant heterogeneity 
between the studies. The reduced risk of HSV-2 infection was of borderline statisti-
cal significance and MC was associated with lower risk of chancroid in six of seven 
studies [80]. More recently, a large review (N = 60) of studies assessed the associa-
tion between MC and women’s health outcomes included six studies on syphilis 
acquisition [47]. All the studies were in developing countries; there were no RCTs. 
The results were that MC was highly protective; all studies reported a reduction in 
syphilis with one reporting no cases of syphilis in the treatment (MC) group [81].
Partners PrEP Study Team followed 4716 HIV sero-discordant couples, of whom 
roughly 50% of the men were circumcised. During the follow-up period (~ 2·75 years), 
MC was associated with significantly fewer cases of syphilis by 42% in men compared 
with uncircumcised men and was most protective for HIV (+) men as demonstrated by 
62% reduction. Further, MC male circumcision reduced overall female partner syphilis 
incidence by 59%; by 75% in the HIV (−) women and a 48% HIV (+) women. Thus, 
MC was strongly associated with reductions in syphilis acquisition in both men and 
their female partners. This suggests that MC decreases syphilis acquisition even in HIV 
discordant couples and should be an option for HIV (+) men in countries employing 
voluntary medical male circumcision to reduce syphilis [77, 82].
5.3 Genital ulcerative disease
Genital ulcerative disease (GUD) is associated with an increased risk of HIV 
acquisition and transmission. The ulcer results from various sexually transmit-
ted infections but the ulcer’s disruption of the skin tissue promotes co-infection 
by other viruses and bacteria. In the United States most genital ulcers are due to 
HSV or syphilis. Less prevalent infectious causes include chancroid (Haemophilus 
ducreyi), granuloma inguinale (Klebsiella granulomatis), and lymphogranuloma 
venereum [83].
Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused 
by certain chlamydia trachomatis strains. LGV is common in certain areas of Africa, 
Southeast Asia, India, the Caribbean, and South America. It is rare in developed 
countries, but in the last 10 years has been increasingly recognized in North 
America, Europe, and the United Kingdom as causing rectal infections among men 
who have sex with men [84]. In the Ugandan RCT, MC reduced the risk of genital 
ulcer disease (GUD) in men by 50% [5] (Table 1).
5.4 Gonorrhea, chlamydia, trichomonas, and bacterial vaginosis infections
These bacterial STIs cause cervicitis, urethritis, vaginitis and genital ulcer-
ation, and some may also infect the rectum and pharynx. Chlamydia and gonor-
rhea are associated with serious short- and long-term conditions such as pelvic 
inflammatory disease, ectopic pregnancy, infertility, chronic pelvic pain and 
arthritis. They also can be transmitted to the newborn infant during pregnancy 
or delivery [36].
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The three African RCTs also reported associations between MC and gonorrhea, 
chlamydia, trichomonas, and bacterial vaginosis (Table 1). The South African trial 
reported reductions with borderline statistical significance in male acquisition 
of chlamydia (44%) and trichomonas (47%) in men with MC [3]. The Kenyan 
study results suggested reductions in chlamydia and trichomonas, but neither was 
statistically significant [4]. Neither study reported an association between MC and 
gonorrhea in men. Gray reported statistically significant reductions in bacterial 
vaginosis (any severity) (40%), severe bacterial vaginosis (61%) and trichomonas 
(48%) in females whose partners had MC [85].
Grund et. al’s review of the impact of MC on women’s health outcomes reported 
high quality evidence that MC was protective of chlamydia, that effect was mod-
erately generalizable, and inclusive of studies from Africa, Americas, Asia, Europe 
and the U.S. In contrast, low consistency evidence was found for MC and female 
acquisition of trichomonas, bacterial vaginosis, and gonorrhea [47].
6. Summary and conclusions
Three African trials of male circumcision in HIV-negative men showed that 
circumcision reduced male acquisition of HIV by 50–60%. As a result, male 
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circumcision is now a recommended strategy for HIV prevention in men in 
developing nations. By reducing the number of new infections in the population, 
the resource burden of HIV treatment is lessened, and fewer women and babies are 
exposed to HIV infection. Nearly 15 million voluntary medical male circumcisions 
(VMMC) have been performed for HIV prevention in 14 countries of eastern and 
southern Africa during the decade since WHO and UNAIDS recommended VMMC 
to be a component of HIV prevention intervention [7, 49]. Swaziland was the first 
country to introduce national early infant male circumcision (EIMC) into VMMC 
programming for HIV prevention [86]. It is estimated that these VMMCs will avert 
over half a million new HIV infections through 2030.
Although MC has not been directly associated with decreases in HIV transmis-
sion to female partners, MC has health promotion benefits for women. High-
consistency evidence exists that male circumcision protects women against cervical 
cancer, cervical dysplasia, herpes simplex virus type 2, chlamydia, and syphilis. 
Even in HIV infected men and women, MC appears to have a role in reducing co-
infection with syphilis and STIs such as chlamydia and gonorrhea.
To date, there are no formal programs for MC, whether for VMMC or EIMC in 
developing countries. However, health care workers in developed and developing 
countries alike must be prepared to counsel parents that choosing EIMC could have 
protective benefits ranging from UTIs in infancy to STIs in adulthood. In addition, 
health care workers must be able to counsel sexually active adolescent and adult 
males not only on safe sex practices, but that MC may be an option to promote their 
health or that of their partner [12, 87] (Figure 4).
Figure 4. 
Male circumcision and infection - information to share adapted from “information for providers to share 
with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually 
transmitted infections, and other health outcomes” - division of HIV/AIDS prevention National Center for 
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
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World-wide, male circumcision is an important component in the arsenal of 
tools to prevent disease. It does not replace but strengthens established approaches 
to prevent and treat infection e.g. avoidance of risky sexual behaviors, condom use, 
anti-viral/antibiotic medications, and vaccinations. The role of male circumcision 
to diminish infections, whether urinary tract or STIs, conserves health resources for 
those with unpreventable illness and more broadly, can play a role in increasing the 
health of the population overall.
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